CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 92 enrolled
Drug / intervention
aromaother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01307748
NCT01307748Phase 3Completed
CompareCT.gov

Physiologic and Expectancy Effects of Stress-reducing Aroma in Older Adults

Oregon Health and Science University·interventional·Posted Mar 3, 2011·Updated Aug 19, 2019

In Brief

A Phase 3 clinical trial evaluating aroma for Stress-related Problems. Completed, enrolled 92 participants across 1 site.

Detailed Summary

The study purpose is to evaluate efficacy of stress-reducing aromatherapy and learn about how aromatherapy works.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStress-related Problems
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMar 3, 2011
Enrollment StartDec 1, 2010
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 15.3 years ago

Interventions

aromaother

Comparison of known stress reducing aroma to placebo aromas without stress-reducing effects